Global Cancer Imaging Systems Market Size, Share and Forecast to 2027

The global Cancer Imaging Systems Market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

Due to movement restrictions and lockdowns due to the current COVID-19 pandemic, the growth of the Cancer Imaging Systems industry is expected to be negatively affected. In addition to the impact of the COVID-19 pandemic on numerous global markets, the Cancer Imaging Systems industry is expected to feel the effect as well. The slowdown in economic growth and dynamic changes in demand will further affect industry growth. The report covers the impact analysis of the COVID-19 pandemic on the overall Cancer Imaging Systems industry.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/222

Key Highlights from the Report

  • In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science instrumentation, including cell imaging systems.
  • MRI offers the benefit of imaging soft body tissue parts that are occasionally hard to view using other types of modalities. MRI is excellent at identifying and locating some cancers. Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor imaging technique.
  • Lung cancer is a common type of cancer in men and the third-leading cancer type in women with 2 million novel cases in the year 2018. Hungary, Serbia, and New Caledonia (France) were the top three countries with the highest disease rate in 2018.
  • Diagnostics centers are projected to grow at the fastest rate of 10.0% in the forecast period. Diagnostic centers are fitted out with the requisite imaging system and specialist staff, as well as healthcare personnel, for assisting in the process of detecting diseases in individuals displaying specific symptoms.

Regional Landscape section of the Cancer Imaging Systems report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

·        North America (U.S., Canada)

·        Europe (U.K., Italy, Germany, France, Rest of EU)

·        Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

·        Latin America (Chile, Brazil, Argentina, Rest of Latin America)

·        Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Competitive Landscape:

The latest study provides an insightful analysis of the broad competitive landscape of the global Women’s Health market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Women’s Healthmarket and pinpoint the fundamental growth trends.  

Key participants include GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.

Request customization of the report https://www.emergenresearch.com/request-for-customization/222

Radical Highlights of the Cancer Imaging Systems Market Report:

·  Comprehensive overview of the Cancer Imaging Systems market along with analysis of the changing dynamics of the market

·        Growth Assessment of various market segments throughout the forecast period

·     Regional and global analysis of the market players, including their market share and global position

·   Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market

·      Impact of the technological developments and R&D advancements on the Cancer Imaging Systems market

·      Information about profit-making strategies and developmental strategies of major companies and manufacturers

·        Insightful information for the new entrants willing to enter the market

·   Details and insights about business expansion strategies, product launches, and other collaborations

·      The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis

Market Overview:

The report bifurcates the Women’s Healthmarket on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Emergen Research has segmented the global cancer imaging systems market on the basis of imaging systems, application, end-users, and region:

Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)

  • Mammography
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Positron Emission Tomography (PET)
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Research Report on the Cancer Imaging Systems Market Addresses the Following Key Questions:

·      Who are the dominant players of the Cancer Imaging Systems market?

·      Which regional market is anticipated to have a high growth rate over the projected period?

·     What consumer trends and demands are expected to influence the operations of the market players in the Cancer Imaging Systems market?

·   What are the key growth drivers and restraining factors of the Cancer Imaging Systems market?

·   What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?

·   What is the overall impact of the COVID-19 pandemic on the Cancer Imaging Systems market and its key segments?

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Comments

Post a Comment